Amicus Therapeutics Inc. added its President and COO Bradley Campbell to the board.
Cranbury, N.J.-based Amicus develops and sells therapies for rare and orphan diseases.
Amicus Therapeutics adds COO to board
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Amicus Therapeutics Inc. added its President and COO Bradley Campbell to the board.
Cranbury, N.J.-based Amicus develops and sells therapies for rare and orphan diseases.